ePrints

Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease

Lookup NU author(s): Alan Leake, Dr Christopher Morris

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Several lines of evidence indicate that there may be an inflammatory component to the pathology of Alzheimer's disease (AD), the major form of degenerative dementia in the elderly. Activity of inflammatory cells, and the elaboration of toxic molecules by such cells may be a significant factor in disease progression. In peripheral inflammatory states, the increased activity of matrix metalloproteinase (MMP) enzymes are a major cause of tissue breakdown and secondary damage in diseases such as rheumatoid arthritis. The activity of such enzymes in the normal or diseased central nervous system is, however, not well characterized. We have therefore determined the levels of MMP 1 (collagenase) in the normal human brain and in AD. MMP1 levels were relatively low though were significantly elevated by approximately 50% in AD in all cortical areas examined. Given the activity towards collagen of MMP1, it is possible that enhanced MMP1 activity in AD, may contribute to the blood-brain barrier dysfunction seen in AD. Published by Elsevier Science Ireland Ltd.

Publication metadata

Author(s): Leake A; Morris CM; Whateley J

Publication type: Article

Publication status: Published

Journal: Neuroscience Letters

Year: 2000

Volume: 291

Issue: 3

Pages: 201-203

ISSN (print): 0304-3940

ISSN (electronic): 1872-7972

Publisher: Elsevier

URL: http://dx.doi.org/10.1016/S0304-3940(00)01418-X

DOI: 10.1016/S0304-3940(00)01418-X

Altmetrics

Share